361 related articles for article (PubMed ID: 25445828)
21. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
[TBL] [Abstract][Full Text] [Related]
22. Does sputum eosinophilia predict the response to systemic corticosteroids in children with difficult asthma?
Lex C; Jenkins G; Wilson NM; Zacharasiewicz A; Erin E; Hansel TT; Bush A; Payne DN
Pediatr Pulmonol; 2007 Mar; 42(3):298-303. PubMed ID: 17262857
[TBL] [Abstract][Full Text] [Related]
23. Eosinophilic Endotype of Asthma.
Aleman F; Lim HF; Nair P
Immunol Allergy Clin North Am; 2016 Aug; 36(3):559-68. PubMed ID: 27401626
[TBL] [Abstract][Full Text] [Related]
24. Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study.
Ohbayashi H; Adachi M
Allergol Int; 2008 Sep; 57(3):231-9. PubMed ID: 18493166
[TBL] [Abstract][Full Text] [Related]
25. Asthma phenotypes: consistency of classification using induced sputum.
Hancox RJ; Cowan DC; Aldridge RE; Cowan JO; Palmay R; Williamson A; Town GI; Taylor DR
Respirology; 2012 Apr; 17(3):461-6. PubMed ID: 22142406
[TBL] [Abstract][Full Text] [Related]
26. Blood eosinophil counts predict treatment response in patients with severe eosinophilic asthma.
Ortega H; Katz L; Gunsoy N; Keene O; Yancey S
J Allergy Clin Immunol; 2015 Sep; 136(3):825-6. PubMed ID: 26194540
[No Abstract] [Full Text] [Related]
27. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma.
Baigelman W; Chodosh S; Pizzuto D; Cupples LA
Am J Med; 1983 Dec; 75(6):929-36. PubMed ID: 6650547
[TBL] [Abstract][Full Text] [Related]
28. Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma.
Hilvering B; Xue L; Pavord ID
Ther Adv Respir Dis; 2015 Aug; 9(4):135-45. PubMed ID: 25900924
[TBL] [Abstract][Full Text] [Related]
29. Benralizumab strongly reduces blood basophils in severe eosinophilic asthma.
Lommatzsch M; Marchewski H; Schwefel G; Stoll P; Virchow JC; Bratke K
Clin Exp Allergy; 2020 Nov; 50(11):1267-1269. PubMed ID: 32762056
[No Abstract] [Full Text] [Related]
30. Safety and application of induced sputum analysis in childhood asthma.
Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
[TBL] [Abstract][Full Text] [Related]
31. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
Siva R; Green RH; Brightling CE; Shelley M; Hargadon B; McKenna S; Monteiro W; Berry M; Parker D; Wardlaw AJ; Pavord ID
Eur Respir J; 2007 May; 29(5):906-13. PubMed ID: 17301099
[TBL] [Abstract][Full Text] [Related]
32. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
Green RH; Brightling CE; McKenna S; Hargadon B; Parker D; Bradding P; Wardlaw AJ; Pavord ID
Lancet; 2002 Nov; 360(9347):1715-21. PubMed ID: 12480423
[TBL] [Abstract][Full Text] [Related]
33. Reslizumab (Cinqair) for severe eosinophilic asthma.
Med Lett Drugs Ther; 2016 Jun; 58(1497):81-2. PubMed ID: 27305070
[No Abstract] [Full Text] [Related]
34. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma.
Niimi A; Matsumoto H; Takemura M; Ueda T; Chin K; Mishima M
Am J Respir Crit Care Med; 2003 Oct; 168(8):983-8. PubMed ID: 12829452
[TBL] [Abstract][Full Text] [Related]
35. Mepolizumab in the treatment of severe eosinophilic asthma: Results from a physician in the field.
Strauss RA; Jawhari N
Ann Allergy Asthma Immunol; 2018 Jul; 121(1):121-123. PubMed ID: 29684570
[No Abstract] [Full Text] [Related]
36. Asthma biomarkers in sputum.
Spahn JD
Immunol Allergy Clin North Am; 2007 Nov; 27(4):607-22; vi. PubMed ID: 17996579
[TBL] [Abstract][Full Text] [Related]
37. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma.
Wagener AH; de Nijs SB; Lutter R; Sousa AR; Weersink EJ; Bel EH; Sterk PJ
Thorax; 2015 Feb; 70(2):115-20. PubMed ID: 25422384
[TBL] [Abstract][Full Text] [Related]
38. Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study.
van Veen IH; Ten Brinke A; Gauw SA; Sterk PJ; Rabe KF; Bel EH
J Allergy Clin Immunol; 2009 Sep; 124(3):615-7, 617.e1-2. PubMed ID: 19733302
[No Abstract] [Full Text] [Related]
39. Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines.
Bossley CJ; Fleming L; Gupta A; Regamey N; Frith J; Oates T; Tsartsali L; Lloyd CM; Bush A; Saglani S
J Allergy Clin Immunol; 2012 Apr; 129(4):974-82.e13. PubMed ID: 22385633
[TBL] [Abstract][Full Text] [Related]
40. Eosinophils and allergy.
Monteseirín J; Prados M; Camacho MJ; Llamas E; de la Calle A; González J; Gutiérrez D; Conde J
Allergol Immunopathol (Madr); 1996; 24(5):201-10. PubMed ID: 8985476
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
